199 related articles for article (PubMed ID: 38397314)
1. Neonatal Abstinence Signs during Treatment: Trajectory, Resurgence and Heterogeneity.
Miller JS; Bada HS; Westgate PM; Sithisarn T; Leggas M
Children (Basel); 2024 Feb; 11(2):. PubMed ID: 38397314
[TBL] [Abstract][Full Text] [Related]
2. Association of a Simplified Finnegan Neonatal Abstinence Scoring Tool With the Need for Pharmacologic Treatment for Neonatal Abstinence Syndrome.
Devlin LA; Breeze JL; Terrin N; Gomez Pomar E; Bada H; Finnegan LP; O'Grady KE; Jones HE; Lester B; Davis JM
JAMA Netw Open; 2020 Apr; 3(4):e202275. PubMed ID: 32267513
[TBL] [Abstract][Full Text] [Related]
3. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
[TBL] [Abstract][Full Text] [Related]
4. Gestational Age Alters Assessment of Neonatal Abstinence Syndrome.
Amiri S; Nair J
Pediatr Rep; 2022 Jan; 14(1):50-57. PubMed ID: 35225878
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.
Davis JM; Shenberger J; Terrin N; Breeze JL; Hudak M; Wachman EM; Marro P; Oliveira EL; Harvey-Wilkes K; Czynski A; Engelhardt B; D'Apolito K; Bogen D; Lester B
JAMA Pediatr; 2018 Aug; 172(8):741-748. PubMed ID: 29913015
[TBL] [Abstract][Full Text] [Related]
6. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS.
Velez ML; Jordan C; Jansson LM
Neurotoxicol Teratol; 2021; 88():107032. PubMed ID: 34600100
[TBL] [Abstract][Full Text] [Related]
7. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
[TBL] [Abstract][Full Text] [Related]
8. Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant.
Schiff DM; Grossman MR
Semin Fetal Neonatal Med; 2019 Apr; 24(2):115-120. PubMed ID: 30738754
[TBL] [Abstract][Full Text] [Related]
9. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach.
Velez ML; Jordan CJ; Jansson LM
Neurotoxicol Teratol; 2021; 88():107020. PubMed ID: 34419619
[TBL] [Abstract][Full Text] [Related]
10. Neonatal abstinence syndrome.
Kocherlakota P
Pediatrics; 2014 Aug; 134(2):e547-61. PubMed ID: 25070299
[TBL] [Abstract][Full Text] [Related]
11. A New Scoring System for the Assessment of Neonatal Abstinence Syndrome.
Kocherlakota P; Qian EC; Patel VC; Mandru C; Vilar RE; Alpan G; La Gamma EF
Am J Perinatol; 2020 Feb; 37(3):333-340. PubMed ID: 31777045
[TBL] [Abstract][Full Text] [Related]
12. A Quality Improvement Initiative to Increase Scoring Consistency and Accuracy of the Finnegan Tool: Challenges in Obtaining Reliable Assessments of Drug Withdrawal in Neonatal Abstinence Syndrome.
Timpson W; Killoran C; Maranda L; Picarillo A; Bloch-Salisbury E
Adv Neonatal Care; 2018 Feb; 18(1):70-78. PubMed ID: 29045256
[TBL] [Abstract][Full Text] [Related]
13. Neonatal abstinence syndrome: Historical perspective, current focus, future directions.
Jones HE; Fielder A
Prev Med; 2015 Nov; 80():12-7. PubMed ID: 26232620
[TBL] [Abstract][Full Text] [Related]
14. Non-pharmacological care for opioid withdrawal in newborns.
Pahl A; Young L; Buus-Frank ME; Marcellus L; Soll R
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013217. PubMed ID: 33348423
[TBL] [Abstract][Full Text] [Related]
15. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
Gaalema DE; Scott TL; Heil SH; Coyle MG; Kaltenbach K; Badger GJ; Arria AM; Stine SM; Martin PR; Jones HE
Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927
[TBL] [Abstract][Full Text] [Related]
16. Improving the Assessment of Neonatal Abstinence Syndrome (NAS).
Chin Foo CA; Dansereau LM; Hawes K; Oliveira EL; Lester BM
Children (Basel); 2021 Aug; 8(8):. PubMed ID: 34438576
[TBL] [Abstract][Full Text] [Related]
17. Validation of hospital discharge coding for neonatal abstinence syndrome.
Yam P; Lok L; Eastwood J; Maher C; Ward M; Clews S; Falconer J; Oei JL
Acta Paediatr; 2019 Oct; 108(10):1786-1792. PubMed ID: 30924956
[TBL] [Abstract][Full Text] [Related]
18. Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA.
Gomez Pomar E; Finnegan LP; Devlin L; Bada H; Concina VA; Ibonia KT; Westgate PM
BMJ Open; 2017 Sep; 7(9):e016176. PubMed ID: 28963285
[TBL] [Abstract][Full Text] [Related]
19. Integrated Review of the Assessment of Newborns With Neonatal Abstinence Syndrome.
Casavant SG; Meegan T; Fleming M; Hussain N; Gork S; Cong X
J Obstet Gynecol Neonatal Nurs; 2021 Sep; 50(5):539-548. PubMed ID: 34116058
[TBL] [Abstract][Full Text] [Related]
20. A case-control study comparing rates and diagnoses of hospital readmission in infants affected by neonatal abstinence syndrome.
Salt E; Wiggins A; Pick A; Bada H; Howard C; Currie M; Rayens MK
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2162820. PubMed ID: 36597833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
